arrow
T

Takayuki Kondo

chiba university
H指数:20
被引数:1,216

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Cytokine release syndrome following durvalumab and tremelimumab in advanced hepatocellular carcinoma: A case report with cytokine and damage-associated molecular pattern analysis
2024-06-291
PRE
Ramucirumab for advanced hepatocellular carcinoma in the current real world: a Japanese single-arm study post-REACH-2 (The R-evolution study)
2024-06-060
OAAI
Assessment of Macrovascular Invasion in Advanced Hepatocellular Carcinoma: Clinical Implications and Treatment Outcomes with Systemic Therapy
2024-05-210
OAAI
Clinical risk factors for portal hypertension-related complications in systemic therapy for hepatocellular carcinoma
2024-04-071
OAAI
Exploring the efficacy of atezolizumab plus bevacizumab for advanced hepatocellular carcinoma in relation to tumor-infiltrating lymphocytes
2024-03-220
PRE
Potential of circulating receptor-interacting protein kinase 3 levels as a marker of acute liver injury
2023-08-282
OAAI
Estimation of the effect of atezolizumab plus bevacizumab on pulmonary arterial hypertension using computed tomography in HCC patients
2023-07-172
OAAI
Alteration of the tumor microenvironment by pharmacological inhibition of EZH2 in hepatocellular carcinoma
2023-05-013
PRE
The efficacy of contrast-enhanced computed tomography on the management of gastroesophageal varices in patients with hepatocellular carcinoma
2022-12-011
OAAI
Clinical effects and emerging issues of atezolizumab plus bevacizumab in patients with advanced hepatocellular carcinoma from Japanese real-world practice

来自日本实际实践的晚期肝细胞癌患者中,阿特珠单抗联合贝伐单抗的临床效果和新出现的问题

CANCER
IF5.1
2022-11-2410
PRE
A diet-induced murine model for non-alcoholic fatty liver disease with obesity and insulin resistance that rapidly develops steatohepatitis and fibrosis
2022-10-0111
PRE
Carbon-ion radiotherapy versus radiofrequency ablation as initial treatment for early-stage hepatocellular carcinoma
2022-09-035
PRE
Management of Systemic Therapies and Hepatic Arterial Infusion Chemotherapy in Patients with Advanced Hepatocellular Carcinoma Based on Sarcopenia Assessment

基于肌肉减少症评估的晚期肝细胞癌患者全身治疗和肝动脉灌注化疗的管理

2022-02-227
OAAI